LUCD News and Press, Lucid Diagnostics Inc. From 08/14/25

PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire Lucid processed 2,756 EsoGuard ® 2Q25 tests, recognized revenue of $1.2 million , and secured CAC meeting on Medicare LCD for EsoGuard to be held on September 4 ...

2025-08-13 16:39:11 ET Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call August 13, 2025 08:30 A.M. ET Company Participants Dennis M. McGrath - Chief Financial Officer Lishan Aklog - Chairman & CEO Matthew Riley - Director of Investor Relations Confer...

2025-08-13 08:28:23 ET More on Lucid Diagnostics Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG Lucid says meeting scheduled to determine Medicare coverage for cancer test Seeking Alpha’s Quant Rating on Lucid Diagnostics Hist...

Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results PR Newswire Processed 2,756 EsoGuard ® tests and recognized 2Q25 revenue of $1.2 million , ending quarter with over $30 million in proforma cash and extending runway w...

Western Uranium & Vanadium Corp (WSTRF) is expected to report for Q2 2025 IceCure Medical Ltd. (ICCM) is expected to report $-0.06 for Q2 2025 TFF Pharmaceuticals Inc - Ordinary Shares (TFFP) is expected to report for quarter end 2025-06-30 Scientific Industries, Inc. (SCND) is ex...

Lucid Diagnostics Inc. (LUCD) is expected to report $-0.1 for Q2 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 13, 2025 PR Newswire Conference Call and Webcast at 8:30 AM Eastern Time NEW YORK , July 30, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Luc...

2025-07-28 14:36:40 ET More on Lucid Diagnostics Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript Lucid says meeting scheduled to determine Medicare coverage for cancer test Lucid Diagnostics signals expanded market reach and $41M pro forma cash ...

2025-07-16 15:35:46 ET More on Lucid Diagnostics, PAVmed PAVmed Inc. (PAVM) Q1 2025 Earnings Call Transcript Lucid Diagnostics Inc. (LUCD) Q1 2025 Business Update Call Transcript Lucid Diagnostics signals expanded market reach and $41M pro forma cash following commer...

MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics' EsoGuard® Esophageal DNA Test PR Newswire Virtual public CAC meeting to be held September 4, 2025 , at 2:00 p.m. ET NEW YORK , July 16, 20...